Navigation Links
Gegevens over één jaar van wereldwijd register voor atriumfibrillatie (AF) tonen dat antitrombosemiddelen niet optimaal worden gebruikt ter voorkoming van beroertes
Date:9/3/2013

ende uitkomsten zullen daarvan deel uitmaken: trombo-embolische beroerte; TIA ("mini-beroertes"); MI/ACS; bloedstollingen die gevolgen hebben voor andere delen van het lichaam; bloedingen; therapietrouw; mate van discontinuering; medische consultaties en ziekenhuisopnames; behoefte aan urgente en electieve ingrepen; cardiovasculaire morbiditeit en overlijden door welke oorzaak dan ook.

Onder patiënten die worden behandeld met vitamine K-antagonisten, omvatten de uitkomstgegevens tevens de frequentie en timing van de controles die vereist zijn om een veilig en therapeutisch effectief niveau van anticoagulatie te waarborgen en de ingrepen die nodig zijn om complicaties als gevolg van de anticoagulatietherapie te beheersen.

Het GARFIELD-register wordt mogelijk gemaakt door een onbeperkte onderzoekssubsidie van Bayer Pharma AG.

De belasting van AF
Tot 2% van de wereldbevolking heeft AF. Meer dan 6 miljoen Europeanen lijden aan deze ritmestoornis en volgens schattingen zal de verspreiding minstens verdubbeld zijn in 2050, omdat de bevolking ouder wordt. Ongeveer 4,5 miljoen mensen in de Europese Unie en 2,6 miljoen mensen in de Verenigde Staten hebben AF en schattingen geven aan dat in 2014 meer dan 12 miljoen mensen in de regio Azië-Stille Oceaan AF zullen hebben.(1,2,3,4) AF leidt tot een 5 keer zo groot risico op een beroerte en één op de vijf van alle beroertes kan worden toegeschreven aan deze ritmestoornis. Ischemische beroertes in combinatie met AF zijn vaak fataal en die patiënten die het wel overleven, krijgen vaker te maken met een ernstigere lichamelijke handicap en hebben een grotere kans op herhaling dan patiënten die een beroerte krijgen vanwege een andere oorzaak. Het gevolg is dat het risico op overlijden aan AF-gerelateerde beroertes twee keer zo groot is en dat de kosten van de zorg toenemen met 50%.(5) De aandoening doet zich voor wanneer delen van de atria ongeco
'/>"/>

SOURCE Thrombosis Research Institute
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Grootschalige wereldwijde registratie voor onderzoek naar behandelingspatronen en ziektelast onder patiënten met veneuze trombo-embolie (VTE)
2. Top buyers including Atico, Coles Group Asia, Kmart, Staples, Office Depot and Target Australia pre-registered to attend Global Sources spring China Sourcing Fairs
3. Attendees Save Up To $800 on Global Healthcare Conferences in 2012 by Registering Through Global Information Inc.
4. Attendees Save up to $350 on CHI Conferences This Summer by Registering Through Global Information
5. Worlds Only USDA Certified Organic and FDA Registered Homeopathic Medicines Guaranteed to Work
6. DATATRAK Expands CDISC Registered Solutions Provider Standards
7. Save Up To 25% on International Biotech and Healthcare, and Pharmaceutical Conferences by Registering Through GII
8. Registered Nurses Provide Immunizations at Walmart Stores Nationwide
9. Neuralstem to Raise $7.0 Million in Registered Direct Offering
10. BioDelivery Sciences Announces $40 Million Registered Financing
11. Kareo Named a Top Workplace by the Orange County Register
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... 23, 2014  SI-BONE, Inc., a medical device company ... ® a minimally invasive surgical (MIS) device indicated ... that the U.S. Patent and Trademark Office has awarded ... for the fixation and fusion of bone.  This newly ... tapered distal end that may be placed from one bone across ...
(Date:9/23/2014)... Sept. 23, 2014 Report Details ... you trends, R&D and predicted revenues Do you ... Now get the latest analysis for those cancer ... opportunities and revenue forecasts. Visiongain,s new report ... kinase inhibition and related technology. There avoid missing ...
(Date:9/23/2014)... , Sept. 23, 2014 EnzymeBioSystems (OTCBB: ... along with the process of evaluating an enzyme ... in fighting tumors. In an effort to evaluate this ... with various contract research organizations to enlist their ... the use of an antitumor natural product called ...
Breaking Medicine Technology:SI-BONE, Inc. Strengthens Patent Portfolio with the U.S. Patent and Trademark Office's Issuance of Threaded, Fenestrated Implant Method Patent 2SI-BONE, Inc. Strengthens Patent Portfolio with the U.S. Patent and Trademark Office's Issuance of Threaded, Fenestrated Implant Method Patent 3Kinase Inhibitors for Treating Cancer: Industry Analysis, R&D Trends and World Market Forecasts 2014-2024 2Kinase Inhibitors for Treating Cancer: Industry Analysis, R&D Trends and World Market Forecasts 2014-2024 3Kinase Inhibitors for Treating Cancer: Industry Analysis, R&D Trends and World Market Forecasts 2014-2024 4Kinase Inhibitors for Treating Cancer: Industry Analysis, R&D Trends and World Market Forecasts 2014-2024 5EnzymeBioSystems Announces Progress with an Enzyme Compound 2
... today reported financial results for the third quarter ended,September ... Novavax reported a net loss of $9.0 million, or ... $5.0 million net loss, or the,equivalent of $0.08 loss ... For the nine months ended September 30, 2007, the ...
... Allos,Therapeutics, Inc. (Nasdaq: ALTH ) today announced ... non-randomized, open-label, multi-center dose,escalation study of the Company,s ... tumors or non-Hodgkin,s lymphoma (NHL). "We are ... said Pablo,J. Cagnoni, M.D., Chief Medical Officer of ...
Cached Medicine Technology:Novavax Reports Third Quarter 2007 Financial Results and Progress with Vaccine Development Programs 2Novavax Reports Third Quarter 2007 Financial Results and Progress with Vaccine Development Programs 3Novavax Reports Third Quarter 2007 Financial Results and Progress with Vaccine Development Programs 4Novavax Reports Third Quarter 2007 Financial Results and Progress with Vaccine Development Programs 5Novavax Reports Third Quarter 2007 Financial Results and Progress with Vaccine Development Programs 6Allos Therapeutics Initiates Study of RH1 in Patients with Advanced Solid Tumors or non-Hodgkin's Lymphoma 2Allos Therapeutics Initiates Study of RH1 in Patients with Advanced Solid Tumors or non-Hodgkin's Lymphoma 3Allos Therapeutics Initiates Study of RH1 in Patients with Advanced Solid Tumors or non-Hodgkin's Lymphoma 4
(Date:9/23/2014)... TUESDAY, Sept. 23, 2014 (HealthDay News) -- A test used ... geographic regions where certain lung infections are more common, a ... lung cancer is through the use of what,s known as ... imaging called FDG-PET is used, according to the study authors. ... do parts of the lungs that don,t have ...
(Date:9/23/2014)... Avid collector Andrew Hawley, from Vintage Rock Posters, ... Seattle concert posters. The Doors were a smash hit after ... The Seattle Eagles Auditorium concert was held on July 23. ... Eagles Auditorium in November the same year. The artist that ... in three colors. The poster is a split fountain silkscreen ...
(Date:9/23/2014)... What: Rutgers Presbyterian Church, a ... that embodies the inclusion and diversity of New ... the Ecological Crisis, a public lecture led by ... of Old Testament at Louisville Presbyterian Seminary. Tull ... lends insight into current ecological problems, including energy ...
(Date:9/23/2014)... A recent Oregon survey about an exercise DVD ... daily routine of elementary school students found it had ... teachers, and offered clear advantages for overly sedentary educational ... and produced by the Healthy Youth Program of the ... available nationally. , Brain Breaks leads children in 5-7 ...
(Date:9/23/2014)... OAK BROOK, Ill. (September 23, 2014) Both ... malignancy with screening computed tomography (CT) colonography greatly ... invasive follow-up tests precipitated by false-positive diagnoses, according ... issue of the journal Radiology . , ... target a specific organ. However, when screening for ...
Breaking Medicine News(10 mins):Health News:Lung Infections May Hamper Ability to Detect Lung Cancer 2Health News:Inhabiting Eden: Christians, Scripture, and the Ecological Crisis – Public Lecture to Discuss Faith-Based Environmentalism 2Health News:'Brain Breaks' increase activity, educational performance in elementary schools 2Health News:'Brain Breaks' increase activity, educational performance in elementary schools 3Health News:Patients accept false-positives to achieve diagnostic sensitivity 2Health News:Patients accept false-positives to achieve diagnostic sensitivity 3
... Completes Renovation of Local ... Pediatrician,s Office, HOUSTON, Dec. ... Office Makeover" for pediatrician Dr.,Muhammad Shaikh at the Bissonet Medical Center ... initiative that AMERIGROUP Community,Care sponsored for the area,s physicians and its ...
... Aida,Pharmaceuticals (OTC Bulletin Board: AIDA) today ... has been named as a "New and,High-Tech ... New High,Technology Service Centre ("SNHTSC"), a special ... Government. This,designation will allow Rh-Apo2L to have ...
... and Treat Alzheimer,s Disease, MORGANTOWN, W.Va., Dec. 4 ... discovered that,a cancer drug - Bryostatin - enhances the ... This drug could potentially increase,normal memory capacity in humans ... disease, stroke and head trauma., In an article ...
... Proceeds Benefit Institute on Aging and the Center for ... Elderly Suicide Prevention (CESP), SAN ... at San Francisco,s War Memorial Veterans Building Green,Room, the Center for ... on Aging (IOA), celebrates their 21st Annual,Cable Car Caroling fundraising event. ...
... Capital Through 2010, LOUISVILLE, Ky., Dec. 4 Almost Family, ... terms of its,previously existing $22.5 million bank credit facility., ... in borrowings with a maturity date of June 2010. -- ... Earnings Before Interest Taxes Depreciation and Amortization ...
... Pa., Dec. 4 The Capital BlueCross Medicare,Advantage ... Keystone,Health Plan Central, was ranked as the No. ... a report issued today by the Pennsylvania,Health Care ... Containment Council is an independent state agency formed ...
Cached Medicine News:Health News:AMERIGROUP Community Care Provides 'Doctor's Office Makeover' in Houston 2Health News:Rh-Apo2L Named as One of China's High-Tech Transforming Products by Chinese Government 2Health News:Drug Found to Create New Connections in Brain, Restoring and Improving Memory 2Health News:Carolers Bring Holiday Cheer to Homebound Seniors 2Health News:Almost Family Announces Expansion of Revolving Credit Facility 2Health News:Almost Family Announces Expansion of Revolving Credit Facility 3Health News:Capital BlueCross HMO Plan is Ranked No. 1 in Pennsylvania for Member Satisfaction 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: